Financhill
Back

Omega Therapeutics Quote, Financials, Valuation and Earnings

Omega Therapeutics Price Quote

$2.58

Omega Therapeutics Key Stats

Sell
46
Omega Therapeutics (OMGA) is a Sell

Day range:
$2.56 - $3.00
52-week range:
$1.30 - $10.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
45.01
P/B ratio:
2.45%

Volume:
394.2K
Avg. volume:
330.9K
1-year change:
-66.58%
Market cap:
$142.3M
Revenue:
$3.1M
EPS:
$-1.8

How Much Does Omega Therapeutics Make?

Is Omega Therapeutics Growing As A Company?

  • What Is Omega Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.35%
  • What Is Omega Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Omega Therapeutics Stock Price Performance

What Is Omega Therapeutics 52-Week High & Low?

Omega Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Omega Therapeutics?

  • How Much Debt Does Omega Therapeutics Have?
    Total long term debt quarterly is $18.9M
  • How Much Cash Does Omega Therapeutics Have?
    Cash and short term investments quarterly total is $73.4M
  • What Is Omega Therapeutics’s Book Value Per Share?
    Book value per share is 1.05

Is Omega Therapeutics Cash Flow Positive?

  • What Is OMGA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$91.5M
  • What Is Omega Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $41.8M
  • What Is Omega Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $47.5M

Omega Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    OMGA return on invested capital is -87.37%
  • What Is Omega Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -51.09%
  • What Is OMGA Return On Equity?
    ROE is a measure of profitability and is -106.14%

Omega Therapeutics Earnings Date & Stock Price

Omega Therapeutics Competitors

  • Who Are Omega Therapeutics's Competitors?
    Below is a list of companies who compete with Omega Therapeutics or are related in some way:
    • Amneal Pharmaceuticals Inc (AMRX)
    • AnaptysBio Inc (ANAB)
    • Fate Therapeutics Inc (FATE)
    • Ocular Therapeutix Inc (OCUL)
    • Stoke Therapeutics Inc (STOK)

Omega Therapeutics Dividend Yield

Data Unavailable

Omega Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.45%
Revenue: 34.56% 86.6%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.00
Upside from Last Price: 326.36%

Major Shareholders

  • How many OMGA shares are owned by institutional investors?
    36.4M OMGA shares are owned by institutional investors
  • How many OMGA shares are owned by insiders?
    934K OMGA shares are owned by insiders